Micrania Melts 5 & 10 mg Orodispersible tablets
PDF Leaflet Revision Date: 21 January 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Acute treatment of migraine attacks in adults.
Dosage (summary)
Adults: 5 mg or 10 mg; max 30 mg in 24 hours.
Onset of Action / Duration
Onset: 30 mins, Duration: Not specified
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- MAO inhibitors
- Propranolol
- SSRIs/SNRIs
- Ergotamine
Contraindications
- Hypersensitivity to rizatriptan
- Uncontrolled hypertension
- Coronary artery disease
- CVA or TIA
- Severe hepatic or renal insufficiency
Common side effects
- Dizziness
- Somnolence
- Fatigue
- Nausea
Counselling Points
- Take as soon as migraine symptoms appear
- Do not exceed recommended dose
- Monitor for signs of serotonin syndrome
Serious warnings
- Risk of coronary vasospasm
- Serotonin syndrome
- Medication overuse headache
Important Disclaimer
The Micrania Melts 5 & 10 mg Orodispersible tablets professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
